UVA Engineering (@uvaengineers) 's Twitter Profile
UVA Engineering

@uvaengineers

University of Virginia School of Engineering and Applied Science

ID: 30226467

linkhttp://engineering.virginia.edu/ calendar_today10-04-2009 14:33:04

5,5K Tweet

6,6K Followers

1,1K Following

UVA Engineering (@uvaengineers) 's Twitter Profile Photo
UVA Engineering
@uvaengineers

8 months ago

Tempo Therapeutics, founded by BME & CHE associate professor Donald Griffin, recently dosed the first patients in their TT101 trial. TT101 is a solution designed to regrow large volumes of tissue while preventing disfiguring scars for skin cancer patients. Bill Epling @uvabme

Tempo Therapeutics, founded by BME &amp; CHE associate professor Donald Griffin, recently dosed the first patients in their TT101 trial. TT101 is a solution designed to regrow large volumes of tissue while preventing disfiguring scars for skin cancer patients. <a href="/uvachechair/">Bill Epling</a> @uvabme